$AIP

Hawkins Nicholas B. sold $113K of AIP

Hawkins Nicholas B. (VP and Chief Financial Officer) sold 3,000 shares of Arteris, Inc. (AIP) at $37.75 ($0.11M total) on 2026-05-26.

Original reporting
SEC EDGAR · Hawkins Nicholas B.
Published May 28, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:44 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIP
Neutral
low confidence
Mentioned
$AIP
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPNeutralLow
01

Why it matters

The newest fact is the disclosed sale size, price, and post-transaction holdings by the CFO; it does not include any new company performance, guidance, or regulatory/legal development.

02

Market read

Traders may monitor for clustering of insider selling, but this single Form 4 does not constitute a standalone fundamental catalyst.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-scheduled personal liquidity needs; without additional context, directional trading is low-conviction.

Relevance 4/10Novelty 2/10Timing: Filed 2026-05-28 after the 2026-05-26 sale.

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for Arteris, Inc.

Company-level read

Ticker impact

$AIPNeutralLow confidence
Context

Arteris CFO Nicholas Hawkins sold 3,000 shares in an open-market transaction at $37.7514 on 2026-05-26, disclosed via Form 4.

Expected impact

Likely limited near-term impact; traders may view it as mild, non-directional signal unless paired with other disclosures.

Evidence & confidence

Form 4 insider sales are common and often non-informational; the filing lacks context on motivations and does not include company-specific operational or financial updates.

Market effects

No clear sector read-through from a single CFO open-market sale.

None indicated.

None indicated.

Counterpoint

The absence of a stated 10b5-1 plan could prompt some traders to interpret the sale as a stronger signal than typical, even though insider-sale filings rarely move fundamentals.

Key entities

  • Arteris, Inc.

    Public company whose CFO insider sale is disclosed on Form 4.

  • Nicholas B. Hawkins

    VP and Chief Financial Officer who sold 3,000 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to